All In MedTech

Company

Nalu Medical

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 21, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $115M raised of $115M sought, first sale Dec 21, 2023, 29 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Dec 21, 2023Equity$115M$115M29Rule 506(b)Form D/A ↗Oct 9, 20242 amendments

1 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Nalu Medical, Inc.
Headquarters
Carlsbad, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    15 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors from funding announcements and the firms' own portfolio pages.

    No 5%+ shareholder filings, SBIR grants or venture investors found under the name Nalu Medical.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    2 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 2303000
    Jan 2414100
    Feb 2402700
    Mar 2413800
    Apr 2404300
    May 2405400
    Jun 2404000
    Jul 2403800
    Aug 2403600
    Sep 2404300
    Oct 2404400
    Nov 2402900
    Dec 2403600
    Jan 2504200
    Feb 2512400
    Mar 2504600
    Apr 2502901
    May 2502800
    Jun 2502000
    Jul 2503600
    Aug 2503600
    Sep 2501900
    Oct 2502400
    Nov 2501600
    Dec 2502000
    Jan 2601200
    Feb 2602900
    Mar 2613200
    Apr 2611200
    May 260000
    Jun 261800
    Jul 261900
    Aug 261801
    Sep 26434400
    Oct 267329730
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    The full in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.